DALLAS, March 18, 2019 (GLOBE NEWSWIRE) -- via
OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts,
Inc.) (KALY) (“KALYâ€) today announced
Professor Jeffry Osbourn, Ph.D., from the University of Kentucky
and the principal of Biomedical Science Research Group (BSRG), and
KALY CEO Frederick Ferri met last week to coordinate a phase two
study of a pilot treatment of Chronic Obstructive Pulmonary
Disease (COPD) in primates with cannabis extracts derived from
Kali-Extracts patented cannabis extraction process. A report
on the first primate study from Professor Jeffry Osbourn is coming
soon. The primate study adds to the Kali-Extracts in
vitro genomics study, previously announced, to evaluate the impact
of its pharmaceutical grade cannabis extracts in combination with
other therapies on COPD patients. The World Health
Organization estimates 65 million people worldwide are afflicted
with moderate to severe COPD and GlobalData forecasts that the COPD
treatment market will reach $14.1 billion by 2025.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The company has made recent advances in partnership with Puration, Inc. (PURA) (“PURAâ€) developing a CBD extract for infusion into a beverage at a 25 mg concentration. The first target beverage for the 25 mg CBD concentrate beverage is a private labeled health water for Generex Biotechnology (GNBT).
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
[email protected]
(214) 210-0459